RenovoRx, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
RenovoRx, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
  • RenovoRx, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.39M, a 2.66% decline year-over-year.
  • RenovoRx, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$8.11M, a 17.9% increase year-over-year.
  • RenovoRx, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$10.2M, a 3.47% decline from 2022.
  • RenovoRx, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$9.89M, a 56.4% decline from 2021.
  • RenovoRx, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$6.32M, a 66.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$8.11M -$2.39M -$62K -2.66% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$8.05M -$1.08M +$2.18M +67% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-13
Q4 2023 -$10.2M -$3.23M -$1.07M -49.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$9.16M -$1.42M +$715K +33.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$9.88M -$2.33M +$267K +10.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$10.1M -$3.26M -$254K -8.46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-13
Q4 2022 -$9.89M -$2.16M +$199K +8.45% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$10.1M -$2.14M -$625K -41.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$9.46M -$2.59M -$1.28M -98% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$8.18M -$3M -$1.86M -162% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$6.32M -$2.36M -$1.48M -168% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$4.85M -$1.51M -$415K -37.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$4.43M -$1.31M -$537K -69.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$3.9M -$1.15M -$97K -9.23% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$3.8M -$878K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$1.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$773K Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$1.05M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.